The refusal of blood transfusions by Jehovah’s Witnesses poses a major challenge in treating acute myeloid leukaemia (AML), ...

Please provide your email address to receive an email when new articles are posted on . The test met its primary endpoint of concordance with intended use, which was 99%. Patients with a positive ...

The Food and Drug Administration has greenlit Japan-based test manufacturer Fujirebio to begin marketing its blood test for helping doctors diagnose Alzheimer's disease in some patients, clearing the ...

ST. LOUIS--(BUSINESS WIRE)--Clinicians worried about early-onset Alzheimer’s disease in patients with cognitive concerns between the ages of 50 and 55 years can now prescribe the PrecivityAD2™ blood ...

The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other ...

It was much more accurate than primary care doctors using cognitive tests and CT scans. The findings could speed the quest for an affordable and accessible way to diagnose patients with memory ...

New research by UCLA Health has found a simple blood test could provide faster and more accurate diagnosis of ALS by ...

Data show screenings are pivotal to early detections especially in demographics where the disease is prevalent.

Galleri should have a good chance to win FDA marketing approval in early 2027. But insurance coverage and widespread adoption ...

Back in May of this year, the FDA approved a new method of human papillomavirus (HPV) testing in a healthcare setting. Rather than a standard Pap smear performed with a speculum -- a test dreaded by ...